Home
>
National Drug Code (NDC)
>
CIPRO
CIPRO - 0065-8531-10 - (ciprofloxacin hydrochloride and hydrocortisone)
Drug Information of CIPRO
| Product NDC: | 0065-8531 |
| Proprietary Name: | CIPRO |
| Non Proprietary Name: | ciprofloxacin hydrochloride and hydrocortisone |
| Active Ingredient(s): | 2; 10 mg/mL; mg/mL & nbsp; ciprofloxacin hydrochloride and hydrocortisone |
| Administration Route(s): | AURICULAR (OTIC) |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CIPRO
| Product NDC: | 0065-8531 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020805 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990315 |
Package Information of CIPRO
| Package NDC: | 0065-8531-10 |
| Package Description: | 10 mL in 1 BOTTLE, GLASS (0065-8531-10) |
NDC Information of CIPRO
| NDC Code | 0065-8531-10 |
| Proprietary Name | CIPRO |
| Package Description | 10 mL in 1 BOTTLE, GLASS (0065-8531-10) |
| Product NDC | 0065-8531 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ciprofloxacin hydrochloride and hydrocortisone |
| Dosage Form Name | SUSPENSION |
| Route Name | AURICULAR (OTIC) |
| Start Marketing Date | 19990315 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE |
| Strength Number | 2; 10 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
